Medical Polymer Market Research 2022

Medical Polymers Market size is expected to garner $19,014 million by 2022, registering a CAGR of 13.0% during the forecast period 2016-2022. Medical polymers are utilized for a variety of human contact and non-contact applications in the medical industry. These materials are chiefly used in the manufacture of medical implants, devices, disposables (gloves, vials, tools), and packaging. Medical polymers are biocompatible in nature and either remain inert or are easily processed by the human body. The growth in investment towards research and development, increase in adoption of medical polymers and development of low cost materials are driving the demand for medical polymers in the healthcare industry.

Get more information on this report : Request Sample Pages

Medical polymers are adopted widely across the healthcare industry with significant efforts to commercialize new medical polymers to meet the specification of high end applications. Demand for polymers in healthcare markets is growing significantly owing to a significant upsurge in the demand for medical implants, whereas demand for implants is growing primarily due to increased incidences of chronic diseases and increasing global geriatric population. The demand for medical polymers is witnessing significant growth in all the regions, due to rapid acceptance and adoption of polymers from product designing to final product manufacturing.

Although several polymers are biocompatible, not all are approved for commercial use. Medical polymers can be classified broadly into resins, elastomers, and biodegradable plastics. Key resins that are widely utilized include polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS), polycarbonate (PC), polyetheretherketones (PEEK), hydrogel (acrylate), acrylonitrile butadiene styrene (ABS), polymethyl methacrylate (PMMA), and polyethylene terephthalate (PET). Major elastomers employed in the medical industry include styrenic block copolymer (SBC), rubber latex thermoplastics polyurethane (TPU), and thermoplastics olefins (TPO). Frequently used biodegradable plastics include polylactic acid (PLA) and polyglycolic acid (PGA). Multiple local as well as global players offer a wide variety of medical polymers.

The key players in the global medical polymers market have adopted various business strategies, such as research and development, product launch, agreement, acquisition, collaboration, expansion, and partnership, to sustain the intense market competition. The stakeholders of the medical polymers market include medical polymer material providers who distribute their products to several end-user industries across the globe. The data pertaining to market players and their strategic moves have been obtained through press releases of companies, blogs, and primary calls to the experts in the industry.

On the basis of type, medical polymers are segmented into resins, elastomers, and biodegradable plastics. Key resins include PVC, PP, PE, PS, PC, PEEK, acrylate, and other resins (ABS, PMMA, and PET). Major elastomers employed in the medical industry include SBC, rubber latex, and other elastomers (TPU, TPO, and others). Commonly used biodegradable plastics include PLA and others (PGA, PLGA, and so on)

Large amounts of investments are ongoing to develop implants and devices using various polymers driven by their versatility and stability. This is further expected to increase the adoption of polymers for medical applications and enhance the attractiveness of the medical polymers market for industry participants.

Resins such as PEEK and PE, especially ultrahigh molecular weight polyethylene (UHMWPE), possess the maximum market potential in the medical polymer segments. These polymers are gaining popularity owing to their structural strength, bio-inertness, commercial viability, and bio-compatibility. PEEK and UHMWPE find increased usage in medical implants, including orthopedic and electronic implantable devices. PP, PC, and other resins, including ABS, PMMA, and PET, also show increased utilization in manufacturing medical devices. These engineering thermoplastics exhibit excellent stability, durability, and formability and are preferred over metals and polymer for designing medical devices and implants.

Get more information on this report : Request Sample Pages

PVC is another key segment used for manufacturing medical devices and disposables. PS is used in human-contact applications owing to its non-toxicity and stability. Acrylates are used to produce hydrogels, which are applicable in wound-care, drug delivery, and tissue engineering. Elastomers are mostly used in sealing, packaging, and disposables such as gloves. Biodegradable plastics including PLA, PGA, and PLGA are being developed for use in disposables and packaging applications as substitutes for PE and PP.

Increase In Adoption Of Medical Polymers Owing To Low Prices And Versatility

Although medical polymers have been used in the industry since a long time, their adoption has gained momentum over the last decade. This sudden rise is attributed to the increase in research to develop alternatives to traditional materials including metal and polymer for use in medical applications. Development of engineering plastics, such as PMMA, PEEK, ABS, and PET, accelerated the medical polymers market growth. These plastics conform with the safety requirements for use in medical implants and devices.

Get more information on this report : Request Sample Pages

Furthermore, medical polymers are available at lower costs compared to metals and polymer. Engineering plastics used as medical polymers can match the structural strength, stability, inertness, durability, and formability of metals and polymer, while being lighter and more resource efficient. Moreover, the supply of medical polymers is more consistent when compared to metals and polymer, which directly depend upon the mining scenario.

Key players profiled in Medical Polymers Market study includes Eastman Chemical Company, Evonik Industries AG, The Dow Chemical Company, Formosa Plastics Corporation USA, Arkema SA, BASF SE, Covestro AG, DSM N.V., Solvay S.A, and Celanese Corporation.

Other prominent players (not profiled) in the value chain include Victrex Plc., DuPont, Tianjin Plastics Research Institute Co. Ltd, Lubrizol Corporation and Bayer.

Get more information on this report : Request Sample Pages

Medical Polymers Market Key Benefits

• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global medical polymers industry.
• In-depth analysis is conducted by constructing market estimations for key market segments between 2014 and 2022.
• Geographically, the medical plastic market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA. It also includes country analysis of major countries in each geographic region.
• This study evaluates competitive landscape and value chain to interpret the competitive environment across various geographies.
• Comprehensive analysis of factors that drive and restrict the growth of the global medical polymer market is provided.
• Exhaustive analysis of the market by type predicts the major material used currently along with the ones that would gain prominence in the future.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the framework.

 Key Market Segments

• By Type
  • Resin
    • Polyvinyl chloride (PVC)
    • Polypropylene (PP)
    • Polyethylene (PE)
    • Polystyrene (PS)
    • Polycarbonate (PC)
    • Polyetheretherketones (PEEK)
    • Hydrogel (Acrylate)
    • Others (Including ABS, PMMA and PET)
  • Elastomer
    • Styrenic block copolymer (SBC)
    • Rubber latex
    • Others (Including TPU, TPV and TPO)
    • Biodegradable
  • Plastics
• By Application
  • Devices
    • Surgical Instruments
    • Diagnostic Equipment
    • Others
  • Implant
    • Orthopaedic Implants
    • Electronic Implants
    • Dental Implants
  • Disposables
  • Packaging
• By Geography
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
    • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Trends
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key Findings

3.2.1 Top Investment Pockets
3.2.2 Top Player Positioning

3.3 Porters Five Forces Analysis

3.3.1 Bargaining Power of Suppliers
3.3.2 Bargaining Power of Buyers
3.3.3 Threat of New Entrants
3.3.4 Threat of Substitutes
3.3.5 Competitive Rivalry

3.4 Regulatory Scenario

3.4.1 U.S. FDA
3.4.2 Europe CE Mark
3.4.3 Ministry of Health, Labour and Welfare (MHLW)

3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Increase in adoption of MEDICAL Polymers owing to low prices and versatility
3.5.1.2 growth in sales of Medical Implants and Devices
3.5.1.3 Rise in Number of FDA Approvals for Performing Clinical Trials to Benefit the Market

3.5.2 Restraints

3.5.2.1 Price volatility and supply constraints
3.5.2.2 Stringent approval process

3.5.3 Opportunities

3.5.3.1 Funding and grants create market opportunities worldwide
3.5.3.2 Patents in biosorbable polymers increasing by more than 30% per year

3.6 Top Winning Strategies

CHAPTER 4 WORLD MEDICAL POLYMERS MARKET, BY TYPE

4.1 Introduction

4.1.1 Market Size and Forecast

4.2 Resins

4.2.1 Key markets trend
4.2.2 Key growth factors and opportunity
4.2.3 Market Size and Forecast

4.3 Elastomers

4.3.1 Key markets trend
4.3.2 Key growth factors and opportunity
4.3.3 Market Size and Forecast

4.4 Biodegradable plastics

4.4.1 Key markets trends
4.4.2 Key growth factors and opportunity
4.4.3 Market Size and Forecast

CHAPTER 5 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION

5.1 Introduction

5.1.1 Market size and forecast

5.2 Devices

5.2.1 Surgical instruments

5.2.1.1 Market size and forecast

5.2.2 Diagnostics equipment

5.2.2.1 Market size and forecast

5.2.3 Others

5.2.3.1 Market size and forecast

5.3 Implants

5.3.1 Market size and forecast
5.3.2 Orthopedic implants

5.3.2.1 Market size and forecast

5.3.3 Electronic implants

5.3.3.1 Market size and forecast

5.3.4 Dental implants

5.3.4.1 Market size and forecast

5.4 Disposables

5.4.1 Market size and forecast

5.5 Packaging

5.5.1 Market size and forecast

CHAPTER 6 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY

6.1 Introduction

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U. S.

6.2.4.1 Market size and forecast

6.2.5 Canada

6.2.5.1 market size and forecast

6.2.6 Mexico

6.2.6.1 market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany

6.3.4.1 Market size and forecast

6.3.5 France

6.3.5.1 market size and forecast

6.3.6 UK

6.3.6.1 market size and forecast

6.3.7 Rest of Europe

6.3.7.1 market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan

6.4.4.1 Market size and forecast

6.4.5 China

6.4.5.1 market size and forecast

6.4.6 India

6.4.6.1 market size and forecast

6.4.7 Rest of Asia-Pacific

6.4.7.1 market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Latin America

6.5.4.1 Market size and forecast

6.5.5 Middle East

6.5.5.1 market size and forecast

6.5.6 Africa

6.5.6.1 market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1 Eastman Chemical Company

7.1.1 Company overview
7.1.2 Operating business segments
7.1.3 Business performance
7.1.4 Key strategic moves & development

7.2 Evonik Industries AG

7.2.1 Company overview
7.2.2 Operating business segments
7.2.3 Business performance
7.2.4 Key strategic moves & development

7.3 The Dow Chemical Company

7.3.1 Company overview
7.3.2 Operating business segments
7.3.3 Business performance
7.3.4 Key strategic moves & development

7.4 Formosa Plastics Corporation USA

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves & development

7.5 Arkema SA

7.5.1 Company overview
7.5.2 Operating business segments
7.5.3 Business performance
7.5.4 Key strategic moves & development

7.6 BASF SE

7.6.1 Company overview
7.6.2 Operating business segments
7.6.3 Business performance
7.6.4 Key strategic moves & development

7.7 Covestro AG

7.7.1 Company overview
7.7.2 Operating business segments
7.7.3 Business performance
7.7.4 Key strategic moves & development

7.8 DSM N.V.

7.8.1 Company overview
7.8.2 Operating business segments
7.8.3 Business performance
7.8.4 Key strategic moves & development

7.9 Solvay S.A

7.9.1 Company overview
7.9.2 Operating business segments
7.9.3 Business performance
7.9.4 Key strategic moves & development

7.10 Celanese Corporation

7.10.1 Company overview
7.10.2 Operating business segments
7.10.3 Business performance
7.10.4 Key strategic moves & development

Other major players in the industry includes

• Victrex Plc.
• DuPont
• Tianjin Plastics Research Institute Co. Ltd,
• Lubrizol Corporation
• Bayer

*Profiles of these players are not included. The same will be included on request

List of Figures

FIG. 1 TOP INVESTMENT POCKETS MEDICAL POLYMERS
FIG. 2 TOP PLAYER POSITIONING MEDICAL POLYMERS
FIG. 3 PORTERS FIVE FORCES ANALYSIS
FIG. 4 TOP FACTORS IMPACTING THE MEDICAL POLYMERS MARKET
FIG. 5 TOP FACTORS IMPACTING GLOBAL MEDICAL IMPLANTS AND DEVICES MARKET
FIG. 6 LIST OF FEW MEDICAL DEVICES MADE FROM POLYMERS
FIG. 7 U.S.: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 8 CANADA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 9 MEXICO: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 10 GERMANY: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 11 FRANCE: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 12 UK: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 13 REST OF EUROPE: MEDICAL POLYMERS MARKET 2014-2022
FIG. 14 JAPAN: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 15 CHINA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 16 INDIA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 17 REST OF ASIA-PACIFIC: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 18 LATIN AMERICA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 19 MIDDLE EAST: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 20 AFRICA: MEDICAL POLYMERS MARKET, 2014-2022
FIG. 21 EASTMAN CHEMICAL COMPANY: REVENUE, 2013-2015 ($MILLION)
FIG. 22 EASTMAN CHEMICAL COMPANY: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 23 EASTMAN CHEMICAL COMPANY: REVENUE, BY GEOGRAPHY (%)
FIG. 24 EVONIK INDUSTRIES AG: REVENUE, 2013-2015 ($MILLION)
FIG. 25 EVONIK INDUSTRIES AG: REVENUE, BY BUSINESS SEGMENT 2015 (%)
FIG. 26 EVONIK INDUSTRIES AG: REVENUE, BY GEOGRAPHY 2015 (%)
FIG. 27 THE DOW CHEMICAL COMPANY: REVENUE, 2013-2015 ($MILLION)
FIG. 28 THE DOW CHEMICAL COMPANY: REVENUE, BY SEGMENTS 2015 (%)
FIG. 29 THE DOW CHEMICAL COMPANY: REVENUE, BY GEOGRAPHY 2015 (%)
FIG. 30 FORMOSA PLASTICS CORPORATION USA: REVENUE, 2013-2015 ($MILLION)
FIG. 31 FORMOSA PLASTICS CORPORATION USA: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIG. 32 FORMOSA PLASTICS CORPORATION USA: REVENUE, BY GEOGRAPHY SEGMENT, 2015 (%)
FIG. 33 ARKEMA SA: REVENUE, 2013-2015 ($MILLION)
FIG. 34 ARKEMA SA: REVENUE, BY SEGMENT, 2015 (%)
FIG. 35 ARKEMA SA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 36 BASF SE: REVENUE, 2013-2015 ($MILLION)
FIG. 37 BASF SE: REVENUE, BY SEGMENT, 2015 (%)
FIG. 38 BASF SE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 39 COVESTRO AG: REVENUE, 2013-2015 ($MILLION)
FIG. 40 COVESTRO AG: REVENUE, BY SEGMENT, 2015 (%)
FIG. 41 COVESTRO AG: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 42 DSM N. V.: REVENUE, 2013-2015 ($MILLION)
FIG. 43 DSM N. V.: REVENUE, BY SEGMENT, 2015 (%)
FIG. 44 DSM N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 45 SOLVAY S.A: REVENUE, 2013-2015 ($MILLION)
FIG. 46 SOLVAY S.A: REVENUE, BY SEGMENT, 2015 (%)
FIG. 47 SOLVAY S.A: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 48 CELANESE CORPORATION: REVENUE, 2013-2015 ($MILLION)
FIG. 49 CELANESE CORPORATION: REVENUE, BY SEGMENT, 2015 (%)
FIG. 50 CELANESE CORPORATION: REVENUE, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 PRICES OF MAJOR MEDICAL POLYMERS
TABLE 2 WORLD MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 3 WORLD MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4 WORLD RESINS MARKET, 2014-2022 (KILO TONS)
TABLE 5 WORLD RESINS MARKET, 2014-2022 ($MILLION)
TABLE 6 WORLD ELASTOMERS MARKET, 2014-2022 (KILO TONS)
TABLE 7 WORLD ELASTOMER MARKET, 2014-2022 ($MILLION)
TABLE 8 WORLD BIODEGRADABLE PLASTICS MARKET, 2014-2022 (KILO TONS)
TABLE 9 WORLD BIODEGRADABLE PLASTICS MARKET, 2014-2022 ($MILLION)
TABLE 10 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 11 WORLD MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 12 WORLD MEDICAL POLYMER SURGICAL INSTRUMENTS MARKET, 2014-2022 (KILO TONS)
TABLE 13 WORLD MEDICAL POLYMER SURGICAL INSTRUMENTS MARKET, 2014-2022 ($MILLION)
TABLE 14 WORLD MEDICAL POLYMER DIAGNOSTICS EQUIPMENT MARKET, 2014-2022 (KILO TONS)
TABLE 15 WORLD MEDICAL POLYMER DIAGNOSTICS EQUIPMENT MARKET, 2014-2022 ($MILLION)
TABLE 16 WORLD MEDICAL POLYMER OTHERS MARKET, 2014-2022 (KILO TONS)
TABLE 17 WORLD MEDICAL POLYMER OTHERS MARKET, 2014-2022 ($MILLION)
TABLE 18 LIST OF FEW FDA-APPROVED IMPLANTABLE MEDICAL DEVICES MANUFACTURED USING POLYMERS
TABLE 19 WORLD MEDICAL POLYMER IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 20 WORLD MEDICAL POLYMER IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 21 WORLD MEDICAL POLYMER ORTHOPEDIC IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 22 WORLD MEDICAL POLYMER ORTHOPEDIC IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 23 WORLD MEDICAL POLYMER ELECTRONIC IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 24 WORLD MEDICAL POLYMER ELECTRONIC IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 25 WORLD MEDICAL POLYMER DENTAL IMPLANTS MARKET, 2014-2022 (KILO TONS)
TABLE 26 WORLD MEDICAL POLYMER DENTAL IMPLANTS MARKET, 2014-2022 ($MILLION)
TABLE 27 WORLD MEDICAL POLYMER DISPOSABLE MARKET 2014-2022 (KILO TONS)
TABLE 28 WORLD MEDICAL POLYMER DISPOSABLE MARKET 2014-2022 ($MILLION)
TABLE 29 WORLD MEDICAL POLYMER PACKAGING MARKET, 2014-2022 (KILO TONS)
TABLE 30 WORLD MEDICAL POLYMER PACKAGING MARKET, 2014-2022 ($MILLION)
TABLE 31 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY 2014-2022 (KILO TONS)
TABLE 32 WORLD MEDICAL POLYMERS MARKET, BY GEOGRAPHY 2014-2022 ($MILLION)
TABLE 33 NORTH AMERICA MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 34 NORTH AMERICA MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 35 NORTH AMERICA MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 36 NORTH AMERICA MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 37 NORTH AMERICA MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 38 NORTH AMERICA MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 39 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 40 EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 41 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 42 EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 43 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 44 EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 45 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 46 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 47 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 48 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 49 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 50 ASIA-PACIFIC MEDICAL POLYMERS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 51 LAMEA MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 (KILO TONS)
TABLE 52 LAMEA MEDICAL POLYMER MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 53 LAMEA MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 (KILO TONS)
TABLE 54 LAMEA MEDICAL POLYMER MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 55 LAMEA MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 (KILO TONS)
TABLE 56 LAMEA MEDICAL POLYMER MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 57 EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 58 EASTMAN CHEMICAL COMPANY: OPERATING SEGMENT
TABLE 59 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
TABLE 60 EVONIK INDUSTRIES AG: OPERATING SEGMENTS
TABLE 61 THE DOW CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 62 THE DOW CHEMICAL COMPANY: OPERATING SEGMENTS
TABLE 63 FORMOSA PLASTICS CORPORATION USA: COMPANY SNAPSHOT
TABLE 64 FORMOSA PLASTICS CORPORATION USA: OPERATING SEGMENTS
TABLE 65 ARKEMA SA: COMPANY SNAPSHOT
TABLE 66 ARKEMA SA: OPERATING SEGMENTS
TABLE 67 BASF SE: COMPANY SNAPSHOT
TABLE 68 BASF SE: OPERATING SEGMENTS
TABLE 69 COVESTRO AG: COMPANY SNAPSHOT
TABLE 70 COVESTRO AG: OPERATING SEGMENTS
TABLE 71 DSM N. V.: COMPANY SNAPSHOT
TABLE 72 DSM N. V.: OPERATING SEGMENTS
TABLE 73 SOLVAY S.A: COMPANY SNAPSHOT
TABLE 74 SOLVAY S.A: OPERATING SEGMENT
TABLE 75 CELANESE CORPORATION: COMPANY SNAPSHOT
TABLE 76 CELANESE CORPORATION: OPERATING SEGMENTS